最新更新 :
28/04/2024
細胞増殖抑制薬   Mitomycin  
注射薬
溶媒内の安定性 混合時の安定性 安定性に影響する因子 互換性 投与経路 引用文献 PDF
   化学構造  

商品名   商品名     

商品名、賦形剤は国、製薬会社ごとに異なることがあります

Ametycine フランス
Crisofimina アルゼンチン
Fatrix チリ
Maximitom アルゼンチン
Maximiton エクアドル
Minazol コロンビア
Mitameta イタリア
Mitem スイス, ドイツ
Mitocin ブラジル
Mitokebir アルゼンチン, エクアドル
Mitolem コロンビア, ベネズエラ
Mitomicina アルゼンチン, イタリア, エクアドル, スペイン, チリ, ペルー, ポルトガル, メキシコ, ルーマニア
Mitomycin アイルランド, アメリカ, イギリス, イタリア, イラン, オーストリア, ギリシア, スウェーデン, スロベニア, デンマーク, トルコ, ドイツ, ニュージーランド, ノルウェー, ハンガリー, フィンランド, ベルギー, ポーランド, マレーシア
Mitomycine オランダ, ルクセンブルグ
Mitotie アルゼンチン, エクアドル, チリ, ペルー
Mitozytrex アメリカ
Mixandex コロンビア, メキシコ
Mutamycin アメリカ
Riptam コロンビア
Ronzine アルゼンチン, ペルー
Urocin ドイツ
引用文献   注射薬   引用文献 : Mitomycin  
形式 出版物
3 雑誌 Trissel LA, Martinez JF.
Compatibility of amifostine with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1995 ; 52: 2208-2212.
81 雑誌 Trissel LA, Martinez JF.
Compatibility of piperacillin sodium plus tazobactam with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1994 ; 51: 672-678.
84 雑誌 Trissel LA, Martinez JF.
Visual, turbidimetric, and particle-content assessment of compatibility of vinorelbine tartrate with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1994 ; 51: 495-499.
99 雑誌 Trissel LA, Martinez JF.
Compatibility of aztreonam with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1995 ; 52: 1086-1090.
169 雑誌 Trissel LA, Martinez JF.
Physical compatibility of melphalan with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1993 ; 50: 2359-2363.
182 雑誌 Trissel LA, Gilbert DL, Martinez JF.
Compatibility of granisetron hydrochloride with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 56-60.
244 雑誌 Trissel LA, Martinez JF.
Compatibility of filgrastim with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1994 ; 51: 1907-1913.
249 雑誌 Trissel LA, Martinez JF.
Compatibility of thiotepa (lyophilized) with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1996 ; 53: 1041-1045.
307 雑誌 Trissel LA, Martinez JF.
Compatibility of allopurinol sodium with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1994 ; 51: 1792-1799.
334 雑誌 Trissel LA, Tramonte SM, Grilley BJ.
Visual compatibility of ondansetron hydrochloride with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1991 ; 48: 988-992.
335 雑誌 Trissel LA, Bready BB, Kwan JW, Santiago NM.
Visual compatibility of sargramostim with selected antineoplasic agents, anti-infectives, or other drugs during simulated Y-site injection.
Am J Hosp Pharm 1992 ; 49: 402-406.
407 雑誌 Quebberman EJ, Hoffman NE, Ausman RK, Hamid AAR.
Stability of mitomycin admixtures.
Am J Hosp Pharm 1985 ; 42: 1750-1754.
485 雑誌 Dorr RT, Liddil JD.
Stability of mitomycin C in different infusion fluids: compatibility with heparin and glucocorticosteroids.
J Oncol Pharm Practice 1995 ; 1: 19-24.
648 雑誌 Das Gupta V.
Stability of mitomycin aqueous solution when stored in tuberculin syringes.
Int J Pharm Compound 1997 ; 1: 282-283.
835 雑誌 Edwards D, Selkirk AB, Taylor RB.
Determination of the stability of mitomycin C by high performance liquid chromatography.
Int J Pharm 1979 ; 4: 21-26.
905 雑誌 Trissel LA, Martinez JF.
Screening teniposide for Y-site physical incompatibilities.
Hosp Pharm 1994 ; 29: 1010-1017.
1026 雑誌 Mayron D, Gennaro AR.
Stability and compatibility of topotecan hydrochloride with selected drugs.
Am J Health-Syst Pharm 1999 ; 56: 875-881.
1178 雑誌 Benvenuto JA, Anderson RW, Kerkof K, Smith RG, Loo TL.
Stability and compatibility of antitumor agents in glass and plastic containers.
Am J Hosp Pharm 1981 ; 38: 1914-1918.
1239 雑誌 Stolk LML, Fruijtier A, Umans .
Stability after freezing and thawing of solutions of mitomycin C in plastic minibags for intravesical use.
Pharm Weekbl [Sci] 1986 ; 8: 286-288.
1410 雑誌 Trissel LA, Martinez JF, Simmons M.
Compatibility of etoposide phosphate with selected drugs during simulated Y-site injection.
J Am Pharm Assoc 1999 ; 39: 141-145.
1423 雑誌 Trissel LA, Martinez JF, Gilbert DL.
Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection.
J Am Pharm Assoc 1999 ; 39: 514-518.
1827 雑誌 Beijnen JH, Van Gijn R, Underberg WJM.
Chemical stability of the antitumor mitomycin C in solutions for intravesical instillation.
J Parenter Sci Technol 1990 ; 44: 332-335.
2247 雑誌 Chan P, Heatherly K, Kupiec T.C, Trissel L.A.
Compatibility of caspofungin acetate injection with other drugs during simulated Y-site coadministration.
Int J Pharm Compound 2008 ; 12, 3: 276-278.
3128 実験 Mitomycine (Amétycine®) - Résumé Caractéristiques du Produit
Prostrakan 2013
3575 実験 Mitomycine (Ametycine®) - Résumé des caractéristiques du produit
Prostrakan 2013
3897 雑誌 Briot T, Truffaut C, Le Quay L, Lebreton A, Lagarce F.
Stability of Reconstituted and Diluted Mitomycin C Solutions in Polypropylene Syringes and Glass Vials.
Pharmaceutical Technology in Hospital Pharmacy 2016 ;1,2:83-89
4154 実験 Bleomycin sulfate- Summary of Product Characteristics
Accord Health Care 2018
4282 雑誌 Myers A-L, Zhang Y-P, Kawedia J-D, Zhou X,. Sobocinski S-M, Metcalfe M-J, Kramer M-A, Dinney C.P.N, Kamat A-M.
Solubilization and Stability of Mitomycin C Solutions Prepared for Intravesical Administration.
Drugs R D 2017
4367 雑誌 Kinast R.M, Akula K.K, DeBarber A.E, Barker G.T, Gardiner S.K, Whitson E, Mansberger S.L.
The Degradation of Mitomycin C Under Various Storage Methods.
J Glaucoma 2016 ; 25, 6: 477-481.
4471 実験 Amétycine 10 mg poudre pour solution injectable - Résumé des caractéristiques du produit - Oct 10, 2019
Kyowa Kirin Pharma 2019
4526 雑誌 Nisse, Y.E, Vigneron J, Zenier H, D'Huart E, Demoré B.
Stability of mitomycin in polypropylene syringes for use in glaucoma surgery.
EJOP 2021 4: 1.
4763 雑誌 Almasi J, Erdnuss F, Thiesen J, Krämer I.
Physicochemical stability of urea-containing Mitomycin C preparations in glass vials (1.0 mg/mL) and plastic syringes (2.0, 0.4, 0.2 mg/mL)
Pharmaceutical Technology in Hospital Pharmacy 2023 ;8,1

  Mentions Légales